NNNN
Anbio Biotechnology Class A Ordinary SharesNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$513.53M
P/E Ratio
78.00
EPS
$0.15
Beta
—
52W High
$55.65
52W Low
$10.50
50-Day MA
$23.31
200-Day MA
$26.43
Dividend Yield
—
Profit Margin
74.10%
Forward P/E
—
PEG Ratio
—
About Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. The company is headquartered in Frankfurt am Main, Germany.
Fundamentals
| Revenue (TTM) | $8.65M |
| Gross Profit (TTM) | $7.54M |
| EBITDA | — |
| Operating Margin | 59.10% |
| Return on Equity | 27.10% |
| Return on Assets | 14.70% |
| Revenue/Share (TTM) | $0.20 |
| Book Value | $0.69 |
| Price-to-Book | 18.14 |
| Price-to-Sales (TTM) | 59.39 |
| EV/Revenue | 61.87 |
| EV/EBITDA | 92.75 |
| Quarterly Earnings Growth (YoY) | 2.80% |
| Quarterly Revenue Growth (YoY) | 73.90% |
| Shares Outstanding | $43.89M |
| Float | $39.69M |
| % Insiders | 4.79% |
| % Institutions | 4.90% |
Historical Volatility
HV 10-Day
84.30%
HV 20-Day
78.46%
HV 30-Day
121.19%
HV 60-Day
103.68%
HV Rank
—
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 7/9/2026